HAX

XFuel is a company focused on producing sustainable and net-zero advanced fuels for the road, marine, and aviation sectors. Founded in 2010 and headquartered in Dublin, Ireland, with additional operations in Palma de Mallorca, Spain, XFuel has developed innovative technology for the efficient conversion of biomass waste into low-carbon fuels. This process results in a clean, drop-in fuel that can be utilized by distributors and consumers globally, offering a cost-effective alternative to traditional fossil fuels. XFuel's production methods lead to up to 85% fewer greenhouse gas emissions compared to conventional fuel production, with a clear pathway towards achieving carbon-neutral and carbon-negative fuel solutions.

XFuel is a company focused on producing sustainable and net-zero advanced fuels for the road, marine, and aviation sectors. Founded in 2010 and headquartered in Dublin, Ireland, with additional operations in Palma de Mallorca, Spain, XFuel has developed innovative technology for the efficient conversion of biomass waste into low-carbon fuels. This process results in a clean, drop-in fuel that can be utilized by distributors and consumers globally, offering a cost-effective alternative to traditional fossil fuels. XFuel's production methods lead to up to 85% fewer greenhouse gas emissions compared to conventional fuel production, with a clear pathway towards achieving carbon-neutral and carbon-negative fuel solutions.

XFuel is a company focused on producing sustainable and net-zero advanced fuels for the road, marine, and aviation sectors. Founded in 2010 and headquartered in Dublin, Ireland, with additional operations in Palma de Mallorca, Spain, XFuel has developed innovative technology for the efficient conversion of biomass waste into low-carbon fuels. This process results in a clean, drop-in fuel that can be utilized by distributors and consumers globally, offering a cost-effective alternative to traditional fossil fuels. XFuel's production methods lead to up to 85% fewer greenhouse gas emissions compared to conventional fuel production, with a clear pathway towards achieving carbon-neutral and carbon-negative fuel solutions.

Intelligent Implants is a bioelectronics company developing an implantable electrical stimulation platform that uses wireless devices to stimulate, steer, and monitor bone growth and tissue recovery. The company designs electrotherapeutic medical devices intended to treat diseases and accelerate healing in bone and other tissues. Its implants enable healthcare providers to control and monitor treatment, supporting decision making in patient care. By integrating data, engineering and medicine, Intelligent Implants aims to bring active, connected medical devices to clinical practice, improving outcomes for individuals with bone conditions and related injuries.

Intelligent Implants is a bioelectronics company developing an implantable electrical stimulation platform that uses wireless devices to stimulate, steer, and monitor bone growth and tissue recovery. The company designs electrotherapeutic medical devices intended to treat diseases and accelerate healing in bone and other tissues. Its implants enable healthcare providers to control and monitor treatment, supporting decision making in patient care. By integrating data, engineering and medicine, Intelligent Implants aims to bring active, connected medical devices to clinical practice, improving outcomes for individuals with bone conditions and related injuries.

Intelligent Implants is a bioelectronics company developing an implantable electrical stimulation platform that uses wireless devices to stimulate, steer, and monitor bone growth and tissue recovery. The company designs electrotherapeutic medical devices intended to treat diseases and accelerate healing in bone and other tissues. Its implants enable healthcare providers to control and monitor treatment, supporting decision making in patient care. By integrating data, engineering and medicine, Intelligent Implants aims to bring active, connected medical devices to clinical practice, improving outcomes for individuals with bone conditions and related injuries.

Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.

Intelligent Implants is a bioelectronics company developing an implantable electrical stimulation platform that uses wireless devices to stimulate, steer, and monitor bone growth and tissue recovery. The company designs electrotherapeutic medical devices intended to treat diseases and accelerate healing in bone and other tissues. Its implants enable healthcare providers to control and monitor treatment, supporting decision making in patient care. By integrating data, engineering and medicine, Intelligent Implants aims to bring active, connected medical devices to clinical practice, improving outcomes for individuals with bone conditions and related injuries.

Intelligent Implants is a bioelectronics company developing an implantable electrical stimulation platform that uses wireless devices to stimulate, steer, and monitor bone growth and tissue recovery. The company designs electrotherapeutic medical devices intended to treat diseases and accelerate healing in bone and other tissues. Its implants enable healthcare providers to control and monitor treatment, supporting decision making in patient care. By integrating data, engineering and medicine, Intelligent Implants aims to bring active, connected medical devices to clinical practice, improving outcomes for individuals with bone conditions and related injuries.